Hims & Hers Health (NYSE: HIMS) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth company has been growing at a fast rate, making it one of the best stocks to own in healthcare of late.

But while the business is growing, investors should be careful not to overlook the challenges the company is facing. Not only is competition potentially ramping up, but a key growth catalyst for the business could be going away soon. Entering trading this week, the stock has fallen by around 15% in value in the past month as investors may already be heading for the exits.

Is Hims & Hers stock in trouble, or is this just a bump in the road for what could still be a great growth investment to buy and hold?

Continue reading

Source Fool.com